Press "Enter" to skip to content

SGLT2(sodium-glucose cotransporter-2) Inhibitors for Diabetes: Drug Safety Communication – Regarding Rare Occurrences of a Serious Infection of the Genital Area

Requiring a new warning about this risk to be added to the prescribing information of all SGLT2 inhibitors and to the patient Medication Guide.

Original source: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm618908.htm

Be First to Comment

Leave a Reply

Your email address will not be published.